2015–2016 Zika virus epidemic

Contents

2015–2016 Zika virus epidemic was a widespread outbreak of Zika virus primarily across Brazil, other parts of South America, Central America, the Caribbean, and Pacific islands during 2015–2016 that provoked international concern from World Health Organization, Pan American Health Organization, and national health authorities such as Centers for Disease Control and Prevention and Ministry of Health (Brazil). The epidemic was associated epidemiologically with clusters of microcephaly and Guillain–Barré syndrome and prompted emergency declarations involving entities like United Nations, GAVI Alliance, National Institutes of Health, and national ministries in affected states such as Colombia, Venezuela, Mexico, Puerto Rico, and French Polynesia.

Background

The outbreak followed earlier detections of Zika virus in 1947 in Zika Forest and later epidemics in Micronesia (2007) and French Polynesia (2013–2014), with virological links traced by laboratories at institutions including Oswaldo Cruz Foundation, Pasteur Institute, Walter Reed Army Institute of Research, London School of Hygiene & Tropical Medicine, and Johns Hopkins University. Entomological and ecological factors involved vectors such as Aedes aegypti and Aedes albopictus, while regional factors invoked travel between hubs like São Paulo, Rio de Janeiro, Miami, Panama City, and Lima. International policies from organizations including World Health Organization, Pan American Health Organization, and World Bank framed preparedness and response planning.

Initial large-scale case detection occurred in Brazil in early 2015 with retrospective analyses linking cases to events in cities such as Natal and Fortaleza, and surveillance escalated after clusters of congenital anomalies reported in Recife and Pernambuco. By late 2015 and early 2016, national reporting expanded across Colombia, El Salvador, Honduras, Jamaica, and Haiti, with exported cases to continental nodes like New York City, Los Angeles, Toronto, and Paris, leading airlines and travel authorities such as IATA and ministries including Ministry of Health (Argentina) to issue advisories. International coordination peaked in February 2016 when World Health Organization declared a Public Health Emergency of International Concern, prompting actions by agencies including Centers for Disease Control and Prevention, European Centre for Disease Prevention and Control, and research programs at Oxford University and Massachusetts General Hospital.

Transmission pathways identified included vector-borne spread via Aedes aegypti and sexual transmission documented in case reports involving travelers between Brazil and Europe; other modes implicated blood transfusion concerns in systems like Brazilian National Blood Program. Clinical presentations ranged from mild febrile illness documented by clinicians in São Paulo General Hospital to severe neurological sequelae such as microcephaly in neonates born in Pernambuco and autoimmune demyelination syndromes like Guillain–Barré syndrome reported in French Polynesia and Colombia. Virological studies by teams at National Institutes of Health, Evandro Chagas Institute, and Pasteur Institute characterized lineage, phylogeny, and neurotropism, prompting investigations by geneticists at Harvard Medical School and University of São Paulo.

Affected countries implemented vector control campaigns using insecticides coordinated by municipal authorities in cities like Rio de Janeiro and Manaus, while national programs such as Brazilian Ministry of Health and Ministry of Health (Colombia) mobilized surveillance, case reporting, and prenatal guidance. International assistance from World Health Organization, Pan American Health Organization, Centers for Disease Control and Prevention, Médecins Sans Frontières, and Red Cross supported laboratory capacity in public health institutes including Fiocruz and Instituto Nacional de Salud (Colombia). Travel advisories issued by Centers for Disease Control and Prevention, Foreign and Commonwealth Office, Ministry of Foreign Affairs (France), and airline regulators influenced events at airports in Miami International Airport, Galeão International Airport, and Tocumen International Airport. Controversial reproductive health guidance involved ministries and courts in countries such as Brazil, El Salvador, and Honduras and discussions with organizations like UNFPA and World Bank about contraceptive access.

The epidemic had demographic, economic, and social impacts on tourism-dependent islands such as Barbados and Dominican Republic and urban centers like Rio de Janeiro, affecting sectors coordinated by agencies such as World Tourism Organization and finance ministries in affected states. Health systems in provinces like Pernambuco and departments like Atlántico Department experienced increased neonatal care needs, rehabilitation services expanded by NGOs including Save the Children and UNICEF, and legal debates about reproductive rights involved courts such as Supreme Federal Court (Brazil). Internationally, the crisis influenced research funding from entities including Bill & Melinda Gates Foundation, regulatory pathways at U.S. Food and Drug Administration, and policy deliberations in assemblies like World Health Assembly.

Scientific and clinical research accelerated with vaccine candidates developed by teams at National Institutes of Health, Walter Reed Army Institute of Research, University of Oxford, Johnson & Johnson, and Inovio Pharmaceuticals, while diagnostic assays were produced by groups at Centers for Disease Control and Prevention and Pasteur Institute. Antiviral and monoclonal antibody efforts involved collaborations across Wellcome Trust, Bill & Melinda Gates Foundation, and biotech firms including Moderna, with clinical trials overseen by institutional review boards at Harvard Medical School and Federal University of Rio de Janeiro. Long-term follow-up studies of affected cohorts have been conducted by universities such as University of California, San Diego, University of São Paulo, and London School of Hygiene & Tropical Medicine to evaluate neurodevelopmental outcomes, informing guidelines by World Health Organization and Pan American Health Organization.

Category:Zika virus outbreaks